Please use this identifier to cite or link to this item: https://www.um.edu.mt/library/oar/handle/123456789/83489
Full metadata record
DC FieldValueLanguage
dc.contributor.authorJuchniewicz, Mateusz-
dc.contributor.authorRzempala, Joanna-
dc.contributor.authorSkweres-Kuchta, Malgorzata-
dc.date.accessioned2021-11-08T09:32:45Z-
dc.date.available2021-11-08T09:32:45Z-
dc.date.issued2021-
dc.identifier.citationJuchniewicz, M., Rzempala, J., & Skweres-Kuchta, M. (2021). Initiating and defining a sustainable project on the example of rare disease therapy. European Research Studies Journal, 24(3), 663-681.en_GB
dc.identifier.urihttps://www.um.edu.mt/library/oar/handle/123456789/83489-
dc.description.abstractPurpose: The main aim of the article was to present the possibilities of improving the definition of orphan therapy implementation projects using the P5 GPM model in the context of reimbursement decisions. Design/Methodology/Approach: Theoretical research aimed at verifying the applicability of the P5 model in the practice of managing the implementation of orphan therapies. In the first part, the authors presented the essence of defining the project. Then, the background for the implementation of orphan therapies has been presented. Findings: The article presents the long-term impact relating to the limitation of the development of innovation and cooperation, as well as competences of the medical staff and the medical environment, exclusion of the patient and his family from the labour market, the increase in logistics costs related to attempts to reach the treatment, which has an impact on the natural environment. All of this results in a reduction in national welfare. The authors indicated that the use of the P5 model allows for a comprehensive analysis of the environment of orphan therapy implementation projects both in the short and long term, linking them with the goals of sustainable development, which in turn will ensure the correct definition of the project and making investment decisions. Practical Implications: Possibility to use the concept in the health technology assessment process for the purposes of the reimbursement decision, taking into account the sustainable development goals. The P5 model can be helpful in defining these types of projects. Originality/Value: A look at the logic of intervention in case of reimbursement of rare disease therapies from the perspective of the SDGs. Indication of the broad long-term impact of the project from the point of view of all its stakeholders. The considerations presented in the article constitute an introduction to empirical research, primarily in the form of case-studies.en_GB
dc.language.isoenen_GB
dc.publisherUniversity of Piraeus. International Strategic Management Associationen_GB
dc.rightsinfo:eu-repo/semantics/openAccessen_GB
dc.subjectProject management -- Case studiesen_GB
dc.subjectSustainable development reporting -- Case studiesen_GB
dc.subjectMedical care -- Case studiesen_GB
dc.subjectRare diseasesen_GB
dc.titleInitiating and defining a sustainable project on the example of rare disease therapyen_GB
dc.typearticleen_GB
dc.rights.holderThe copyright of this work belongs to the author(s)/publisher. The rights of this work are as defined by the appropriate Copyright Legislation or as modified by any successive legislation. Users may access this work and can make use of the information contained in accordance with the Copyright Legislation provided that the author must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the prior permission of the copyright holderen_GB
dc.description.reviewedpeer-revieweden_GB
dc.identifier.doi10.35808/ersj/2377-
dc.publication.titleEuropean Research Studies Journalen_GB
Appears in Collections:European Research Studies Journal, Volume 24, Issue 3

Files in This Item:
File Description SizeFormat 
Initiating_and_defining_a_sustainable_project_on_the_example_of_rare_disease_therapy.pdf509.51 kBAdobe PDFView/Open


Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.